The microenvironment in antibiotic susceptibility testing
APMIS · 2024-12 · 132 (12) · 985-991
DOI: 10.1111/apm.13405 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift APMIS, online erschienen am 02.04.2024. Verfasst von Niels Høiby und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Microbial Sensitivity Tests, Pseudomonas aeruginosa, Culture Media. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Antibiotic susceptibility testing (AST) by agar diffusion has been repeatedly standardized and, in most cases, gives results which predict clinical success when antibiotic treatment is based on such results. The formation of the inhibition zone is due to a transition from planktonic to biofilm mode of growth. The kinetics of the interaction of antibiotics with bacteria is similar during AST by agar diffusion and during administration of antibiotics to the patients. However, the Mueller‐Hinton agar (MHA) recommended for AST agar diffusion test is fundamentally different from the composition of the interstitial fluid in the human body where the infections take place and human cells do not thrive in MH media. Use of RPMI 1640 medium designed for growth of eucaryotic cells for AST of Pseudomonas aeruginosa against azithromycin results in lower minimal inhibitory concentration, compared to results obtained by MHA. The reason is that the RPMI 1640 medium increases uptake and reduces efflux of azithromycin compared to MHA. During treatment of cystic fibrosis patients with azithromycin, mutational resistance occur which is not detected by AST with MHA. Whether this is the case with other antibiotics and bacteria is not known but it is of clinical importance to be studied.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.
- Institute of Immunology and Microbiology, Panum Institute, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Niels Høiby, Oana Ciofu
Zitieren
APA
Høiby, N., Moser, C., & Ciofu, O. (2024). The microenvironment in antibiotic susceptibility testing. APMIS, 132(12), 985-991. https://doi.org/10.1111/apm.13405
Vancouver
Høiby N, Moser C, Ciofu O. The microenvironment in antibiotic susceptibility testing. APMIS. 2024;132(12):985-991. doi:10.1111/apm.13405
BibTeX
@article{Hiby2024,
author = {Høiby, Niels and Moser, Claus and Ciofu, Oana},
title = {The microenvironment in antibiotic susceptibility testing},
journal = {APMIS},
year = {2024},
volume = {132},
number = {12},
pages = {985--991},
doi = {10.1111/apm.13405}
}
EUVIMED